Pioneering gene therapy takes aim at inherited blindness

(University of Alberta Faculty of Medicine & Dentistry) Canada's first human gene therapy trial for eyes -- the replacement of a faulty gene with a healthy one -- is now underway at Edmonton's Royal Alexandra Hospital to preserve and potentially restore vision for people with choroideremia, a genetic disorder that leaves them blind by middle age.